<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458512450627</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458512450627</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Short Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ramagopalan</surname><given-names>Sreeram V</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512450627">1</xref>
<xref ref-type="aff" rid="aff2-1352458512450627">2</xref>
<xref ref-type="aff" rid="aff3-1352458512450627">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Giovannoni</surname><given-names>Gavin</given-names></name>
<xref ref-type="aff" rid="aff3-1352458512450627">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yeates</surname><given-names>David G</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512450627">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Seagroatt</surname><given-names>Valerie</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512450627">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Goldacre</surname><given-names>Michael J</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512450627">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458512450627"><label>1</label>Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK</aff>
<aff id="aff2-1352458512450627"><label>2</label>Department of Clinical Neurology, University of Oxford, Oxford, UK</aff>
<aff id="aff3-1352458512450627"><label>3</label>Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, UK</aff>
<aff id="aff4-1352458512450627"><label>4</label>Unit of Health-Care Epidemiology, Department of Public Health, University of Oxford, Oxford, UK</aff>
<author-notes>
<corresp id="corresp1-1352458512450627">Professor Michael J Goldacre, Unit of Health-Care Epidemiology, Department of Public Health, University of Oxford, Oxford, OX3 7LF, UK. Email: <email>michael.goldacre@dph.ox.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>3</issue>
<fpage>359</fpage>
<lpage>361</lpage>
<history>
<date date-type="received">
<day>5</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>5</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>5</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Infectious mononucleosis (IM) is associated with the risk of developing multiple sclerosis (MS). Using databases of hospital admissions for England (1999–2005), we investigated the female-to-male ratios (FMRs) for admission to hospital for IM and MS stratified by age. Males were more frequently admitted for IM for all age groups apart from ages 10–14 (FMR 1.50; 95% confidence interval (CI) 1.36–1.64) and, borderline significantly, at ages 15–19 (FMR 1.03, 95% CI 0.99–1.08). This intriguing aspect of IM epidemiology in adolescence, the atypical female excess, may be linked to the sex ratio of MS, where females predominate from adolescence.</p>
</abstract>
<kwd-group>
<kwd>multiple sclerosis</kwd>
<kwd>Epstein-Barr virus</kwd>
<kwd>infectious mononucleosis</kwd>
<kwd>epidemiology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1352458512450627" sec-type="intro">
<title>Introduction</title>
<p>Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by myelin loss, varying degrees of axonal pathology and progressive neurological dysfunction.<sup><xref ref-type="bibr" rid="bibr1-1352458512450627">1</xref></sup> The aetiology of MS remains elusive. However, as with all complex traits, genetic and environmental components have important roles, both independently and interactively, in disease susceptibility.<sup><xref ref-type="bibr" rid="bibr1-1352458512450627">1</xref></sup></p>
<p>MS is more common in females than males<sup><xref ref-type="bibr" rid="bibr2-1352458512450627">2</xref></sup> for an as yet unknown reason. The risk of MS is also increased in individuals with a clinical history of infectious mononucleosis (IM) as a result of Epstein–Barr virus (EBV) infection.<sup><xref ref-type="bibr" rid="bibr1-1352458512450627">1</xref></sup> The age at which IM develops is thought to be important in determining increased MS susceptibility<sup><xref ref-type="bibr" rid="bibr3-1352458512450627">3</xref></sup> and there is some evidence to suggest that a history of IM may confer differential risk for MS depending upon gender.<sup><xref ref-type="bibr" rid="bibr4-1352458512450627">4</xref></sup> In the present study we sought to explore the age- and sex-specific demographic profiles of IM which potentially may have some bearing on the preponderance of MS in females.</p>
</sec>
<sec id="section2-1352458512450627" sec-type="methods">
<title>Methods</title>
<p>We analysed data on hospital admissions for IM using a file of linked hospital admission statistics, built from the English national Hospital Episode Statistics (HES) system, covering all admissions to NHS hospitals in England in the 7 years from 1 April 1998 to 31 March 2005 (population: 51 million). The file was built by the staff of the Oxford record linkage group. We restricted the age range to 1–79 years. We identified cases of IM as code B27 in the tenth revision of the International Classification of Diseases (ICD). The HES system includes data about all people who go through a formal process of admission to hospital (including that for day care as well as for overnight stays). Age-specific rates for males and females were calculated for IM, using the resident population of England in each age group as denominators. Female-to-male ratios (FMRs) of the rates, and their 95% confidence intervals (CIs), were estimated by Poisson regression, taking the observed number of events /patients as a Poisson variable with the logarithm of the population as the offset. Significance was assessed in comparison to a FMR of one and judged using 95% CIs.</p>
<p>We undertook the same calculations for hospital admissions for people with MS, using the ICD code G35 to identify them. Using data linkage, we identified each person only once for each disease, IM or MS, regardless of how many admissions each person had for each disease; and recorded age as the age at first known admission for the disease.</p>
</sec>
<sec id="section3-1352458512450627" sec-type="results">
<title>Results</title>
<p>There were 15,271 people admitted to hospital for IM in England between 1998 and 2005, as recorded in the HES database. Admissions for IM were far more common, as expected, in children and young adults than in older people, with a striking peak in rates at age 10–19 (<xref ref-type="table" rid="table1-1352458512450627">Table 1</xref>). For all but those aged 10–19, there was a substantial male excess, in most cases the FMR was significantly less than one (<xref ref-type="table" rid="table1-1352458512450627">Table 1</xref>). In contrast, in the age group 10–14, the rates for females was significantly higher than for males, and for those aged 15–19 years, the rates for males and females were similar (<xref ref-type="table" rid="table1-1352458512450627">Table 1</xref>).</p>
<table-wrap id="table1-1352458512450627" position="float">
<label>Table 1.</label>
<caption>
<p>Numbers of females and males with infectious mononucleosis or multiple sclerosis; and female-to-male sex ratios (with 95% confidence intervals).</p>
</caption>
<graphic alternate-form-of="table1-1352458512450627" xlink:href="10.1177_1352458512450627-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Age</th>
<th align="center" colspan="4">Infectious mononucleosis<hr/></th>
<th align="center" colspan="4">Multiple sclerosis<hr/></th>
</tr>
<tr>
<th/>
<th align="center" colspan="2">Number<hr/></th>
<th align="left" colspan="2">Ratio, F:M</th>
<th align="center" colspan="2">Number<hr/></th>
<th align="left" colspan="2">Ratio, F:M</th>
</tr>
<tr>
<th/>
<th align="center">Female</th>
<th align="center">Male</th>
<th/>
<th/>
<th align="center">Female</th>
<th align="center">Male</th>
<th/>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>&lt;5</td>
<td>238</td>
<td>439</td>
<td>0.57</td>
<td>(0.48–0.67)</td>
<td>6</td>
<td>4</td>
<td>1.58</td>
<td>(0.43–5.72)</td>
</tr>
<tr>
<td>5–9</td>
<td>386</td>
<td>549</td>
<td>0.74</td>
<td>(0.65–0.84)</td>
<td>5</td>
<td>6</td>
<td>0.87</td>
<td>(0.27–2.56)</td>
</tr>
<tr>
<td>10–14</td>
<td>1069</td>
<td>750</td>
<td>1.50</td>
<td>(1.36–1.64)</td>
<td>14</td>
<td>11</td>
<td>1.34</td>
<td>(0.64–2.98)</td>
</tr>
<tr>
<td>15–19</td>
<td>3420</td>
<td>3459</td>
<td>1.03</td>
<td>(0.99–1.08)</td>
<td>151</td>
<td>80</td>
<td>1.97</td>
<td>(1.52–2.61)</td>
</tr>
<tr>
<td>20–24</td>
<td>791</td>
<td>1654</td>
<td>0.48</td>
<td>(0.44–0.52)</td>
<td>635</td>
<td>243</td>
<td>2.60</td>
<td>(2.26–3.03)</td>
</tr>
<tr>
<td>25–29</td>
<td>280</td>
<td>678</td>
<td>0.41</td>
<td>(0.35–0.47)</td>
<td>1619</td>
<td>614</td>
<td>2.60</td>
<td>(2.37–2.86)</td>
</tr>
<tr>
<td>30–34</td>
<td>187</td>
<td>392</td>
<td>0.47</td>
<td>(0.39–0.56)</td>
<td>2790</td>
<td>1157</td>
<td>2.37</td>
<td>(2.22–2.54)</td>
</tr>
<tr>
<td>35–39</td>
<td>137</td>
<td>244</td>
<td>0.55</td>
<td>(0.45–0.68)</td>
<td>3908</td>
<td>1619</td>
<td>2.38</td>
<td>(2.25–2.53)</td>
</tr>
<tr>
<td>40–44</td>
<td>78</td>
<td>118</td>
<td>0.65</td>
<td>(0.49–0.86)</td>
<td>4485</td>
<td>1946</td>
<td>2.28</td>
<td>(2.16–2.40)</td>
</tr>
<tr>
<td>45–49</td>
<td>48</td>
<td>94</td>
<td>0.50</td>
<td>(0.35–0.70)</td>
<td>5291</td>
<td>2214</td>
<td>2.35</td>
<td>(2.24–2.47)</td>
</tr>
<tr>
<td>50–54</td>
<td>43</td>
<td>68</td>
<td>0.62</td>
<td>(0.42–0.90)</td>
<td>5635</td>
<td>2559</td>
<td>2.17</td>
<td>(2.07–2.27)</td>
</tr>
<tr>
<td>55–59</td>
<td>35</td>
<td>40</td>
<td>0.86</td>
<td>(0.54–1.34)</td>
<td>4479</td>
<td>2317</td>
<td>1.90</td>
<td>(1.80–1.99)</td>
</tr>
<tr>
<td>60–64</td>
<td>28</td>
<td>20</td>
<td>1.35</td>
<td>(0.79–2.44)</td>
<td>3291</td>
<td>1771</td>
<td>1.79</td>
<td>(1.69–1.90)</td>
</tr>
<tr>
<td>65–69</td>
<td>12</td>
<td>18</td>
<td>0.62</td>
<td>(0.29–1.20)</td>
<td>2669</td>
<td>1359</td>
<td>1.81</td>
<td>(1.70–1.94)</td>
</tr>
<tr>
<td>70–74</td>
<td>7</td>
<td>9</td>
<td>0.65</td>
<td>(0.24–1.60)</td>
<td>2268</td>
<td>1031</td>
<td>1.84</td>
<td>(1.71–1.94)</td>
</tr>
<tr>
<td>75+</td>
<td>22</td>
<td>11</td>
<td>1.11</td>
<td>(0.53–2.34)</td>
<td>2876</td>
<td>1104</td>
<td>1.52</td>
<td>(1.42–1.63)</td>
</tr>
<tr>
<td>All ages</td>
<td>6780</td>
<td>8543</td>
<td>0.76</td>
<td>(0.73–0.78)</td>
<td>40,122</td>
<td>18,035</td>
<td>2.12</td>
<td>(2.09–2.16)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>As expected MS was much more common in females than males. The FMR for MS was significantly higher than one at ages 15–19, 20–24 and 25–29 (1.97 [1.50–2.60], 2.60 [2.24–3.03] and 2.60 [2.36–2.86], respectively), and was significantly higher than one throughout the rest of the age range.</p>
</sec>
<sec id="section4-1352458512450627" sec-type="discussion">
<title>Discussion</title>
<p>The female preponderance for hospitalized IM around adolescence is intriguing. It is around this age range when IM is thought to confer the highest risk for MS.<sup><xref ref-type="bibr" rid="bibr5-1352458512450627">5</xref></sup> Thus, speculatively, the greater prevalence of severe IM in females than males at this age may play a role in determining the increased risk of MS in females. This would also fit with data from the population of children with MS, in which the sex ratio is close to unity.<sup><xref ref-type="bibr" rid="bibr6-1352458512450627">6</xref></sup> We cannot readily explain the sex differences in age at presentation of IM, but possible explanations are differences in the immune response between males and females around the time of puberty, and that this exaggerated immune response may lead to autoimmunity in later life. If IM is an initiating factor for MS in some people, it may have a relatively short latent period from infection to MS in some and a long latent period in others. Our data show a significant excess in the FMR for MS in the age group 15–19, following the significant excess in the FMR in IM in the age group 10–14. Thereafter, the FMR excess for MS continues to be found.</p>
<p>Our study has limitations, as we only analysed hospitalization for IM. We did not have data from general practitioner records and thus we would underestimate milder cases of IM. However, diagnoses made in general practice are probably not as accurate as those made in hospital. Furthermore, studies of the frequency of all cases of IM in various regions in the USA found strikingly similar results to the data we present here.<sup><xref ref-type="bibr" rid="bibr7-1352458512450627">7</xref>,<xref ref-type="bibr" rid="bibr8-1352458512450627">8</xref></sup> It may also be that more severe cases of IM increase the risk of MS to a greater extent that milder cases.</p>
<p>Given the data presented here, we feel it is worth considering EBV infection as potentially playing a part in determining the sex ratio of MS. However, the exact role, if any, of EBV in MS remains to be elucidated.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This study was funded by the Medical Research Council (grant number G0801976) and the English National Institute for Health Research. The views expressed in the paper are not necessarily those of the funding bodies.</p>
</fn>
<fn fn-type="conflict">
<label>Conflicts of interest</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458512450627">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ramagopalan</surname><given-names>SV</given-names></name>
<name><surname>Dobson</surname><given-names>R</given-names></name>
<name><surname>Meier</surname><given-names>UC</given-names></name>
<name><surname>Giovannoni</surname><given-names>G</given-names></name>
</person-group>. <article-title>Multiple sclerosis: risk factors, prodromes, and potential causal pathways</article-title>. <source>Lancet Neurol</source> <year>2010</year>; <volume>9</volume>: <fpage>727</fpage>–<lpage>739</lpage>.</citation>
</ref>
<ref id="bibr2-1352458512450627">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herrera</surname><given-names>BM</given-names></name>
<name><surname>Yee</surname><given-names>IM</given-names></name>
<name><surname>Orton</surname><given-names>S-M</given-names></name>
<etal/>
</person-group>. <article-title>Sex ratio of multiple sclerosis in Canada: a longitudinal study</article-title>. <source>Lancet Neurol</source> <year>2006</year>; <volume>5</volume>: <fpage>932</fpage>–<lpage>936</lpage>.</citation>
</ref>
<ref id="bibr3-1352458512450627">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hernán</surname><given-names>MA</given-names></name>
<name><surname>Zhang</surname><given-names>SM</given-names></name>
<name><surname>Lipworth</surname><given-names>L</given-names></name>
<name><surname>Olek</surname><given-names>MJ</given-names></name>
<name><surname>Ascherio</surname><given-names>A</given-names></name>
</person-group> <article-title>Multiple sclerosis and age at infection with common viruses</article-title>. <source>Epidemiology</source> <year>2001</year>; <volume>12</volume>: <fpage>301</fpage>–<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr4-1352458512450627">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahlgren</surname><given-names>C</given-names></name>
<name><surname>Torén</surname><given-names>K</given-names></name>
<name><surname>Odén</surname><given-names>A</given-names></name>
<name><surname>Andersen</surname><given-names>O</given-names></name>
</person-group> <article-title>A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk</article-title>. <source>Eur J Epidemiol</source> <year>2009</year>; <volume>24</volume>: <fpage>541</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr5-1352458512450627">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rostgaard</surname><given-names>K</given-names></name>
<name><surname>Nielsen</surname><given-names>NM</given-names></name>
<name><surname>Nielsen</surname><given-names>TR</given-names></name>
<etal/>
</person-group>. <article-title>Multiple sclerosis after infectious mononucleosis</article-title>. <source>Arch Neurol</source> <year>2007</year>; <volume>64</volume>: <fpage>72</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr6-1352458512450627">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krupp</surname><given-names>L</given-names></name>
<name><surname>Kennedy</surname><given-names>J</given-names></name>
<name><surname>Banwell</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study</article-title>. <source>Lancet Neurol</source> <year>2007</year>; <volume>6</volume>: <fpage>773</fpage>–<lpage>781</lpage>.</citation>
</ref>
<ref id="bibr7-1352458512450627">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heath</surname><given-names>CW</given-names><suffix>Jr</suffix></name>
<name><surname>Brodsky</surname><given-names>AL</given-names></name>
<name><surname>Potolsky</surname><given-names>AI</given-names></name>
</person-group> <article-title>Infectious mononucleosis in a general population</article-title>. <source>Am J Epidemiol</source> <year>1972</year>; <volume>95</volume>: <fpage>46</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr8-1352458512450627">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henke</surname><given-names>CE</given-names></name>
<name><surname>Kurland</surname><given-names>LT</given-names></name>
<name><surname>Elveback</surname><given-names>LR</given-names></name>
</person-group> <article-title>Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969</article-title>. <source>Am J Epidemiol</source> <year>1973</year>; <volume>98</volume>: <fpage>483</fpage>–<lpage>490</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>